An interventional study of pneumococcal conjugate vaccine(prevenar) in Pneumococcal Disease, sponsored by King Saud University. Status unknown. Open to participants aged 3 Weeks to 5 Years. Per ClinicalTrials.gov, last updated 2009-02-13.
Sponsored by King Saud University · Not applicable, Interventional, and Screening
The purpose of this study is to identify the S. pneumoniae serotypes strains and to determine antibiotic susceptibility.
281 studies on the registry are indexed under Pneumococcal Infections; 27 are open to participants now.
This study's planned enrollment of 400 is close to the median of 379 across 230 interventional studies indexed under Pneumococcal Infections.
Browse Pneumococcal Infections studies →King Saud University is the lead sponsor of 164 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
to see the vaccine impact on pneumococcal diseases
Incidence and serotypes of invasive pneumococcal dis.
Time frame: 6-8 months
Antibiotic susceptibility
Time frame: 6-8 months
No study locations are listed for this record.
This study is status unknown, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King Saud University